
UTI Stock Forecast & Price Target
UTI Analyst Ratings
Bulls say
Universal Technical Institute Inc. is poised for continued strong performance, supported by strong underlying demand and the execution of its North Star Strategy, which aims for a revenue compound annual growth rate (CAGR) of approximately 10% through a combination of same-store growth and new program launches. The strategy also targets an expansion of the adjusted EBITDA margin to around 20% by fiscal year 2029, up from 14% in fiscal year 2024. Moreover, the stock has demonstrated significant upward momentum, increasing 29% year-to-date and trading at a premium to its peer group in the postsecondary education sector.
Bears say
Universal Technical Institute Inc. anticipates a decrease in adjusted EBITDA for FY/26 to $115.1 million, reflecting a margin decline to 12.8% from the previous 15.3%, alongside a reduction in GAAP EPS estimates to $0.90, indicating a year-over-year decrease of 13.5%. The forecast also highlights consistent declines in key financial metrics for both FY/26 and FY/27, with lower adjusted EBITDA and GAAP EPS expected amidst increased strategic growth investments. Additionally, while there are projections for improved revenue and earnings in FY/28 and FY/29, the immediate outlook for Q4/25 suggests stagnation, with a projected adjusted EBITDA of $36.3 million decreasing by 2.6% year-over-year and GAAP EPS expected to drop by 29.4%.
This aggregate rating is based on analysts' research of Universal Technical Institute and is not a guaranteed prediction by Public.com or investment advice.
UTI Analyst Forecast & Price Prediction
Start investing in UTI
Order type
Buy in
Order amount
Est. shares
0 shares